These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 4980975)
1. Wilson's disease: the role of penicillamine. Carmichael BM Mil Med; 1969 Oct; 134(11):1336-9. PubMed ID: 4980975 [No Abstract] [Full Text] [Related]
2. Effects of penicillamine therapy and low-copper diet on dysarthria in Wilson's disease (hepatolenticular degeneration). Berry WR; Aronson AE; Darley FL; Goldstein NP Mayo Clin Proc; 1974 Jun; 49(6):405-8. PubMed ID: 4835812 [No Abstract] [Full Text] [Related]
3. Treatment of Wilson's disease (hepatolenticular degeneration) with penicillamine and low-copper diet. Goldstein NP; Tauxe WN; McCall JT; Gross JB; Randall RV Trans Am Neurol Assoc; 1969; 94():34-7. PubMed ID: 5374484 [No Abstract] [Full Text] [Related]
4. Treatment of Wilson's disease. Brewer GJ; Yuzbasiyan-Gurkan V; Young AB Semin Neurol; 1987 Jun; 7(2):209-20. PubMed ID: 3332455 [No Abstract] [Full Text] [Related]
5. Deterioration of Wilson's disease following the start of penicillamine therapy. Pall HS; Williams AC; Blake DR Arch Neurol; 1989 Apr; 46(4):359-61. PubMed ID: 2705894 [No Abstract] [Full Text] [Related]
6. [Long-term treatment of Wilson's disease with D-penicillamine. Report on 20 cases]. Lange J Dtsch Med Wochenschr; 1967 Sep; 92(37):1657-62. PubMed ID: 6054323 [No Abstract] [Full Text] [Related]
7. [Liver copper determination in long-term treatment of Wilson's disease with D-penicillamine]. Lange J; Brandt G Med Welt; 1981 Jan; 32(3):109-10. PubMed ID: 7207132 [No Abstract] [Full Text] [Related]
8. Introduction. Symposium on copper metabolism and Wilson's disease. Goldstein NP; Owen CA Mayo Clin Proc; 1974 Jun; 49(6):363-7. PubMed ID: 4599351 [No Abstract] [Full Text] [Related]
10. Epileptic status immediately after initiation of D-penicillamine therapy in a patient with Wilson's disease. Berger B; Mader I; Damjanovic K; Niesen WD; Stich O Clin Neurol Neurosurg; 2014 Dec; 127():122-4. PubMed ID: 25459257 [No Abstract] [Full Text] [Related]
11. [Regression of a Kayser-Fleischer ring in a case of Wilson's disease during penicillamine therapy (author's transl)]. Hiti H; Harpf H; Wutz W; Schmut O Klin Monbl Augenheilkd; 1980 Feb; 176(2):235-8. PubMed ID: 7420971 [TBL] [Abstract][Full Text] [Related]
14. Ophthalmoscopic changes in a patient with Wilson's disease during long-term penicillamine therapy. Dingle J; Havener WH Ann Ophthalmol; 1978 Sep; 10(9):1227-30. PubMed ID: 736410 [TBL] [Abstract][Full Text] [Related]
15. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease. Hanukoglu A; Curiel B; Berkowitz D; Levine A; Sack J; Lorberboym M J Pediatr; 2008 Dec; 153(6):864-6. PubMed ID: 19014823 [TBL] [Abstract][Full Text] [Related]
16. Treatment of Wilson's disease: in D-penicillamine we trust--what about zinc? Lipsky MA; Gollan JL Hepatology; 1987; 7(3):593-5. PubMed ID: 3570170 [No Abstract] [Full Text] [Related]
17. [Cutis hyperelastica following prolonged administration of penicillamine in a patient with Wilson's disease]. Charlebois G; Cadotte M; Barbeau A Union Med Can; 1972 May; 101(5):893-5. PubMed ID: 4666894 [No Abstract] [Full Text] [Related]
18. Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride. Walshe JM Q J Med; 1973 Jul; 42(167):441-52. PubMed ID: 4728043 [No Abstract] [Full Text] [Related]
19. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine]. D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825 [No Abstract] [Full Text] [Related]